News

Filter

Ferring Pharma acquires two Ph III-ready orthobiologics from BioSET

Ferring Pharma acquires two Ph III-ready orthobiologics from BioSET

19-02-2015

Privately-held Switzerland-headquartered Ferring Pharmaceuticals has acquired the assets of USA-based…

AmplexFerring PharmaceuticalsLicensingPharmaceuticalPrefixSwitzerland

TxCell and Ferring collaborate with Trizell on lead product Ovasave

TxCell and Ferring collaborate with Trizell on lead product Ovasave

04-01-2015

French biotech firm TxCell on Friday announced a further enhancement to the development of its lead product…

BiotechnologyFerring PharmaceuticalsGastro-intestinalsLicensingOvaSaveResearchTrizell HoldingTxCell

Ferring Pharma regains rights to DDAVP portfolio

Ferring Pharma regains rights to DDAVP portfolio

22-10-2014

Privately-held Switzerland-headquartered Ferring Pharmaceuticals says it has acquired DDAVP (desmopressin…

DDAVPDiabetesFerring PharmaceuticalsGenito-urinaryLicensingPharmaceuticalSanofiSwitzerland

Ferring in up to 76 million euro deal with TxCell for IBD drug Ovasave

Ferring in up to 76 million euro deal with TxCell for IBD drug Ovasave

17-03-2014

French biotech firm TxCell SA and privately-held Switzerland-headquartered Ferring International have…

BiotechnologyFerring PharmaceuticalsFinancialGastro-intestinalsLicensingOvaSaveTxCell

Ferring Pharma gains rights for elobixibat from Albireo

05-07-2012

Swiss drugmaker Ferring Pharmaceuticals has entered into a licensing agreement with Albireo AB, a Sweden-based…

AlbireoBiotechnologyelobixibatFerring PharmaceuticalsGastro-intestinalsLicensingPharmaceutical

Ferring acquires Lysteda from Xanodyne, which aims to focus on pain sector; second deal for the firms

11-05-2010

Switzerland-based Ferring Pharmaceuticals has entered an agreement that will expand its Women's Health…

Ferring PharmaceuticalsLicensingLystedaNeurologicalPharmaceuticalReproductiveXanodyne PharmaceuticalsZipsor

COMPANY SPOTLIGHT

Menarini

Back to top